Dna modifying enzymes and active fragments and variants thereof and methods of use
AssigneeLifeEDIT Therapeutics, Inc.
InventorsTyson D. Bowen, Alexandra Briner Crawley, Tedd D. Elich
Life of this patent
Estimating the term…
Loading patent…
AssigneeLifeEDIT Therapeutics, Inc.
InventorsTyson D. Bowen, Alexandra Briner Crawley, Tedd D. Elich
Estimating the term…
Compositions and methods comprising novel deaminase polypeptides for targeted editing of nucleic acids are provided. Compositions comprise deaminase polypeptides. Also provided are fusion proteins comprising a DNA-binding polypeptide and a deaminase of the invention. The fusion proteins include RNA-guided nucleases fused to deaminases, optionally in complex with guide RNAs. Compositions also include nucleic acid molecules encoding the deaminases or the fusion proteins. Vectors and host cells comprising the nucleic acid molecules encoding the deaminases or the fusion proteins are also provided.
A nucleic acid molecule comprising a polynucleotide encoding a deaminase polypeptide, wherein the deaminase polypeptide has adenine deaminase activity and is encoded by a nucleotide sequence that
A nucleic acid molecule comprising a polynucleotide encoding a fusion protein, wherein said fusion protein comprises:
Dependencies are inferred from the claim text.